Epidemiology of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
暂无分享,去创建一个
[1] K. Okajima,et al. Congenital bile duct cysts: Classification, operative procedures, and review of thirty-seven cases including cancer arising from choledochal cyst. , 1977, American journal of surgery.
[2] 田畑 正久. Bacteria and gallstones etiological significance , 1981 .
[3] D. Rattner,et al. Abnormalities of the pancreatic and biliary ducts in adult patients with choledochal cysts. , 1983, Archives of surgery.
[4] H. Takehara,et al. Nationwide survey of cases of choledochal cyst. Analysis of coexistent anomalies, complications and surgical treatment in 645 cases. , 1984, Surgical gastroenterology.
[5] F. Schaffner,et al. Nonalcoholic fatty liver disease. , 1986, Progress in liver diseases.
[6] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.
[7] P. Johnson,et al. Etiologic and clinical characteristics of peripheral and hilar cholangiocarcinoma , 1991, Cancer.
[8] H. Akkız,et al. by Harwood Academic Publishers Printed in India Endoscopic Retrograde Cholangiopancreatography in the Diagnosis and Management of Choledochal Cysts , 1996 .
[9] P. Bedossa,et al. Natural history of liver fibrosis progression in patients with chronic hepatitis C , 1997, The Lancet.
[10] P Boffetta,et al. A meta‐analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma , 1998, International journal of cancer.
[11] Y. Atomi,et al. Pancreatic disorders associated with anomalous pancreaticobiliary junction. , 1999, Surgery.
[12] A. Toki,et al. Bile duct cancer developed after cyst excision for choledochal cyst. , 1999, Journal of hepato-biliary-pancreatic surgery.
[13] H. Adami,et al. Primary liver cancer, other malignancies, and mortality risks following porphyria: a cohort study in Denmark and Sweden. , 1999, American journal of epidemiology.
[14] H. Margolis,et al. The past incidence of hepatitis C virus infection: Implications for the future burden of chronic liver disease in the United States , 2000, Hepatology.
[15] J. Kaldor,et al. Estimating progression to cirrhosis in chronic hepatitis C virus infection , 2001, Hepatology.
[16] S. Porru,et al. Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women. , 2002, American journal of epidemiology.
[17] R. Hultcrantz,et al. Cancer risk in patients with hereditary hemochromatosis and in their first-degree relatives. , 2003, Gastroenterology.
[18] K. McGlynn,et al. The Continuing Increase in the Incidence of Hepatocellular Carcinoma in the United States: An Update , 2003, Annals of Internal Medicine.
[19] B. Grant,et al. Prevalence and Co-Occurrence of Substance Use Disorders and Independent Mood and Anxiety Disorders , 2004, Archives of general psychiatry.
[20] K. McGlynn,et al. Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? , 2004, Journal of hepatology.
[21] H. El‐Serag,et al. The epidemiology of cholangiocarcinoma. , 2004, Seminars in liver disease.
[22] Oliver N Keene,et al. Lamivudine for patients with chronic hepatitis B and advanced liver disease. , 2004, The New England journal of medicine.
[23] B. Bacon,et al. Relation of hemochromatosis with hepatocellular carcinoma: epidemiology, natural history, pathophysiology, screening, treatment, and prevention. , 2005, The Medical clinics of North America.
[24] S. Bird,et al. Influence of alcohol on the progression of hepatitis C virus infection: a meta-analysis. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[25] D. Levy,et al. Recent trends in smoking and the role of public policies: results from the SimSmoke tobacco control policy simulation model. , 2005, Addiction.
[26] Shiyuan Liu,et al. A meta-analysis of case–control studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma in China , 2005, British Journal of Cancer.
[27] F. Nakayama,et al. Bacteria and gallstones , 1981, Digestive Diseases and Sciences.
[28] D. Parkin,et al. The global health burden of infection‐associated cancers in the year 2002 , 2006, International journal of cancer.
[29] H. El‐Serag,et al. The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[30] B. Bell,et al. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. , 2006, Journal of hepatology.
[31] K. Lindor. Characteristics of primary sclerosing cholangitis in the USA , 2007, Hepatology research : the official journal of the Japan Society of Hepatology.
[32] Claude Bouchard,et al. Effects of bariatric surgery on mortality in Swedish obese subjects. , 2007, The New England journal of medicine.
[33] J. Olsen,et al. Risk factors for intrahepatic cholangiocarcinoma in a low‐risk population: A nationwide case‐control study , 2007, International journal of cancer.
[34] B. Graubard,et al. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[35] S. Larsson,et al. Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies , 2007, British Journal of Cancer.
[36] D. Dempsey,et al. Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects , 2008 .
[37] A. Tavill,et al. Liver Disease in Alpha 1-Antitrypsin Deficiency: A Review , 2008, The American Journal of Gastroenterology.
[38] Manal M. Hassan,et al. Effect of different types of smoking and synergism with hepatitis C virus on risk of hepatocellular carcinoma in American men and women: Case‐control study , 2008, International journal of cancer.
[39] K. Straif,et al. Meta-analysis of epidemiologic studies on cigarette smoking and liver cancer. , 2009, International journal of epidemiology.
[40] C. H. Lee,et al. Viral hepatitis-associated intrahepatic cholangiocarcinoma shares common disease processes with hepatocellular carcinoma , 2009, British Journal of Cancer.
[41] H. El‐Serag,et al. Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: A population‐based study of U.S. veterans , 2009, Hepatology.
[42] M. Mondelli,et al. Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma development: a meta-analysis. , 2009, Journal of hepatology.
[43] S. Harrison,et al. Nonalcoholic fatty liver disease and hepatocellular carcinoma: A weighty connection , 2010, Hepatology.
[44] G. Zanette,et al. Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease , 2010, Liver international : official journal of the International Association for the Study of the Liver.
[45] Lequn Li,et al. Evaluation of Risk Factors and Clinicopathologic Features for Intrahepatic Cholangiocarcinoma in Southern China: A Possible Role of Hepatitis B Virus , 2011, Annals of Surgical Oncology.
[46] Y. Kuo,et al. Antiviral therapy reduces risk of hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis. , 2010, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[47] D. Harnois,et al. Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression , 2010 .
[48] Manal M. Hassan,et al. Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma , 2010, Cancer.
[49] A. Baranova,et al. Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults , 2011, Alimentary pharmacology & therapeutics.
[50] T. Therneau,et al. Cirrhosis is present in most patients with hepatitis B and hepatocellular carcinoma. , 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[51] William M. Lee,et al. Maintenance peginterferon therapy and other factors associated with hepatocellular carcinoma in patients with advanced hepatitis C. , 2011, Gastroenterology.
[52] S. Altekruse,et al. Histological classification of liver and intrahepatic bile duct cancers in SEER registries. , 2011, Journal of registry management.
[53] Joel Z Stengel,et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. , 2011, Gastroenterology.
[54] B. Graubard,et al. Metabolic syndrome increases the risk of primary liver cancer in the United States: A study in the SEER‐medicare database , 2011, Hepatology.
[55] N. Chalasani,et al. Nonalcoholic fatty liver disease (NAFLD): Is it really a serious condition? , 2012, Hepatology.
[56] H. El‐Serag,et al. Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review. , 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[57] H. El‐Serag,et al. 458 The Rising Incidence of Hepatocellular Carcinoma in the United States: an Update , 2012 .
[58] J. Shieh,et al. Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies , 2012, Gut.
[59] W. Palmer,et al. Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma. , 2012, Journal of hepatology.
[60] Jasmin A. Tiro,et al. Failure Rates in the Hepatocellular Carcinoma Surveillance Process , 2012, Cancer Prevention Research.
[61] Katherine M Flegal,et al. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. , 2012, JAMA.
[62] S. Lemon,et al. Is hepatitis C virus carcinogenic? , 2012, Gastroenterology.
[63] H. El‐Serag,et al. Epidemiology of viral hepatitis and hepatocellular carcinoma. , 2012, Gastroenterology.
[64] Paolo Chiodini,et al. Metabolic Syndrome and Risk of Cancer , 2012, Diabetes Care.
[65] M. Murad,et al. Anti-Diabetic Medications and the Risk of Hepatocellular Cancer: A Systematic Review and Meta-Analysis , 2013, The American Journal of Gastroenterology.
[66] N. Yang,et al. Characteristics of intrahepatic cholangiocarcinoma in patients with hepatitis B virus infection: clinicopathologic study of resected tumours , 2013, Journal of viral hepatitis.
[67] Masahira Hattori,et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome , 2013, Nature.
[68] C. Cho,et al. Clinical-guide risk prediction of hepatocellular carcinoma development in chronic hepatitis C patients after interferon-based therapy , 2013, British Journal of Cancer.
[69] B. Graubard,et al. Population-Attributable Fractions of Risk Factors for Hepatocellular Carcinoma in the United States , 2013, The American Journal of Gastroenterology.
[70] Sahil Mittal,et al. Epidemiology of hepatocellular carcinoma: consider the population. , 2013, Journal of clinical gastroenterology.
[71] T. Therneau,et al. Risk factors for intrahepatic cholangiocarcinoma: Association between metformin use and reduced cancer risk , 2013, Hepatology.
[72] U. Nöthlings,et al. Abdominal obesity, weight gain during adulthood and risk of liver and biliary tract cancer in a European cohort , 2013, International journal of cancer.
[73] C. Pairojkul,et al. Roles of liver fluke infection as risk factor for cholangiocarcinoma , 2014, Journal of hepato-biliary-pancreatic sciences.
[74] H. El‐Serag,et al. Secular Trends in the Incidence of Cholangiocarcinoma in the USA and the Impact of Misclassification , 2014, Digestive Diseases and Sciences.
[75] Carlo La Vecchia,et al. Hepatocellular carcinoma epidemiology. , 2014, Best practice & research. Clinical gastroenterology.
[76] M. Thiele,et al. Large Variations in Risk of Hepatocellular Carcinoma and Mortality in Treatment Naïve Hepatitis B Patients: Systematic Review with Meta-Analyses , 2014, PloS one.
[77] Benjamin D. Smith,et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. , 2014, Cancer research.
[78] M. Karin,et al. ER stress cooperates with hypernutrition to trigger TNF-dependent spontaneous HCC development. , 2014, Cancer cell.
[79] L. Kaplan,et al. Obesity and liver disease: the epidemic of the twenty-first century. , 2014, Clinics in liver disease.
[80] H. El‐Serag,et al. HCV genotype 3 is associated with an increased risk of cirrhosis and hepatocellular cancer in a national sample of U.S. Veterans with HCV , 2014, Hepatology.
[81] J. Buring,et al. Coffee Consumption and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma by Sex: The Liver Cancer Pooling Project , 2015, Cancer Epidemiology, Biomarkers & Prevention.
[82] J. Ioannidis,et al. Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies , 2015, BMJ : British Medical Journal.
[83] F. Sung,et al. Combination Therapy of Metformin and Statin May Decrease Hepatocellular Carcinoma Among Diabetic Patients in Asia , 2015, Medicine.
[84] B. Wang,et al. Effect of type 2 diabetes mellitus on the risk for hepatocellular carcinoma in chronic liver diseases: a meta-analysis of cohort studies , 2015, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[85] L. Hou,et al. NSAID Use and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: The Liver Cancer Pooling Project , 2015, Cancer Prevention Research.
[86] L. Henry,et al. Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009 , 2015, Hepatology.
[87] Hao Li,et al. Hepatitis C virus infection and the risk of intrahepatic cholangiocarcinoma and extrahepatic cholangiocarcinoma: evidence from a systematic review and meta-analysis of 16 case-control studies , 2015, World Journal of Surgical Oncology.
[88] A. Bondi,et al. Possible association between hepatitis C virus and malignancies different from hepatocellular carcinoma: A systematic review. , 2015, World journal of gastroenterology.
[89] A. Jemal,et al. Cancer statistics, 2016 , 2016, CA: a cancer journal for clinicians.
[90] L. Roberts,et al. Biliary tract cancers: epidemiology, molecular pathogenesis and genetic risk associations. , 2016, Chinese clinical oncology.
[91] B. Graubard,et al. Population attributable fractions of risk factors for hepatocellular carcinoma in the United States , 2016, Cancer.
[92] M. Braddock,et al. Systematic Review with Network Meta-Analysis: Antidiabetic Medication and Risk of Hepatocellular Carcinoma , 2016, Scientific Reports.
[93] S. Kottilil,et al. Hepatitis C genotype 3 disease , 2016, Hepatology International.
[94] R. Wong,et al. Sex‐specific and race/ethnicity‐specific disparities in cholangiocarcinoma incidence and prevalence in the USA: An updated analysis of the 2000–2011 Surveillance, Epidemiology and End Results registry , 2016, Hepatology research : the official journal of the Japan Society of Hepatology.
[95] K. Flegal,et al. Trends in Obesity Among Adults in the United States, 2005 to 2014. , 2016, JAMA.
[96] Peter J. Richardson,et al. Risk of hepatocellular carcinoma after sustained virological response in Veterans with hepatitis C virus infection , 2016, Hepatology.
[97] P. Rosenberg,et al. Future of Hepatocellular Carcinoma Incidence in the United States Forecast Through 2030. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[98] H. El‐Serag,et al. Hepatocellular Carcinoma in the Absence of Cirrhosis in United States Veterans is Associated With Nonalcoholic Fatty Liver Disease. , 2016, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[99] E. Kang,et al. Effect of statin on hepatocellular carcinoma in patients with type 2 diabetes: A nationwide nested case‐control study , 2017, International journal of cancer.
[100] C. la Vecchia,et al. Coffee and the risk of hepatocellular carcinoma and chronic liver disease: a systematic review and meta-analysis of prospective studies , 2017, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[101] H. El‐Serag,et al. Incidence of Hepatocellular Carcinoma in All 50 United States, From 2000 Through 2012. , 2017, Gastroenterology.
[102] V. Cogliano. International Agency for Research on Cancer (IARC) , 2018, The Grants Register 2019.